This technology combines an advanced multi-hit mouse model with integrated computational analysis to generate a highly relevant platform for therapeutic target discovery related to lung transplant complications. It employs a model that simulates the clinical conditions of donor lungs by incorporating brain death, major trauma, and hemorrhagic shock to induce diffuse alveolar damage akin to that seen in Primary Graft Dysfunction. The system uses RNA sequencing data from both mouse and human tissues along with genomic datasets such as TCGA. By analyzing cell death and inflammatory pathways, including necroptosis and apoptosis, the platform efficiently identifies potential drug targets and evaluates existing approved drugs for repurposing.